8:36 AM; Abstract No. 103 - Management of tongue venous malformation

Abstract

PurposeTo determine the efficacy of ethanol embolization in management of tongue vascular malformations.Materials and MethodsThirty-nine patients (22 females, 17 males; mean age: 38 years) presented to my service with tongue vascular malformations. Forty-seven patients had undergone 61 failed previous procedures (embo, laser, surgery, steroid injection, alpha-interpheron, radiation). All patients had baseline arteriograms and MRs. All patients underwent transcath and/or direct puncture ethanol therapy.ResultsOf 39 patients with venous-lymphatic malformations, 18 patients had dramatic reduction and 21 patients' therapy on-going with concurrent reductions (mean f/up: 60 months). One patient with AVM required additional surgery and 1 patient with mixed veno-lymphatic malformation required surgical debulking of excess tissues. Minor complications such as tongue blisters (9 instances) healed spontaneously; 3 tongue injuries healed spontaneously; 3 infections responded to antibiotic treatment; 1 focal numbness resolved.ConclusionEthanol embolotherapy is a primary form of therapy to eradicate high-flow and low-flow vascular malformations of the tongue permanently at long-term follow-up. Rarely is concurrent surgery required. Ethanol sclerotherapy is a curative treatment. PurposeTo determine the efficacy of ethanol embolization in management of tongue vascular malformations. To determine the efficacy of ethanol embolization in management of tongue vascular malformations. Materials and MethodsThirty-nine patients (22 females, 17 males; mean age: 38 years) presented to my service with tongue vascular malformations. Forty-seven patients had undergone 61 failed previous procedures (embo, laser, surgery, steroid injection, alpha-interpheron, radiation). All patients had baseline arteriograms and MRs. All patients underwent transcath and/or direct puncture ethanol therapy. Thirty-nine patients (22 females, 17 males; mean age: 38 years) presented to my service with tongue vascular malformations. Forty-seven patients had undergone 61 failed previous procedures (embo, laser, surgery, steroid injection, alpha-interpheron, radiation). All patients had baseline arteriograms and MRs. All patients underwent transcath and/or direct puncture ethanol therapy. ResultsOf 39 patients with venous-lymphatic malformations, 18 patients had dramatic reduction and 21 patients' therapy on-going with concurrent reductions (mean f/up: 60 months). One patient with AVM required additional surgery and 1 patient with mixed veno-lymphatic malformation required surgical debulking of excess tissues. Minor complications such as tongue blisters (9 instances) healed spontaneously; 3 tongue injuries healed spontaneously; 3 infections responded to antibiotic treatment; 1 focal numbness resolved. Of 39 patients with venous-lymphatic malformations, 18 patients had dramatic reduction and 21 patients' therapy on-going with concurrent reductions (mean f/up: 60 months). One patient with AVM required additional surgery and 1 patient with mixed veno-lymphatic malformation required surgical debulking of excess tissues. Minor complications such as tongue blisters (9 instances) healed spontaneously; 3 tongue injuries healed spontaneously; 3 infections responded to antibiotic treatment; 1 focal numbness resolved. ConclusionEthanol embolotherapy is a primary form of therapy to eradicate high-flow and low-flow vascular malformations of the tongue permanently at long-term follow-up. Rarely is concurrent surgery required. Ethanol sclerotherapy is a curative treatment. Ethanol embolotherapy is a primary form of therapy to eradicate high-flow and low-flow vascular malformations of the tongue permanently at long-term follow-up. Rarely is concurrent surgery required. Ethanol sclerotherapy is a curative treatment.